Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics. Read more about cookies

Amber Wezenaar

PhD student
Amber Wezenaar
Amber Wezenaar

Unraveling behavior and efficacy of engineered T cells for the treatment of cancer using 3D imaging and organoid technology.

Phone 088 97 27 680

--

  • Single-cell transcriptomics reveals immune suppression and cell states predictive of patient outcomes in rhabdomyosarcoma

    • jan. 2023
    • Jeff, DeMartino, et al
    • Nature communications
  • Uncovering the mode of action of engineered T cells in patient cancer organoids

    • jan. 2022
    • Johanna F., Dekkers, et al
    • Nature Biotechnology
View all publications